Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs.
Business Model:
Revenue: $31.4M
Employees: 51-200
Pregenen was acquired by
Bluebird Bio.
The acquisition happend on 2014-07-01.
Details of the transaction were not public
Address: 454 N 34th St
City: Seattle
State: WA
Zip: 98103
Country: US
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs. They work with our partners to apply their tools, services and reagents to increase the reliability, efficacy and safety of a new wave of therapies harnessing the specificity and functional power of molecules and cells produced by the body.
Contact Phone:
+12063628724
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|